| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |